Moral Distress with Obstacles to Hepatitis C Treatment: A Council of Academic Family Medicine Educational Research Alliance (CERA) Study of Family Medicine Program Directors

References

1. 1.↵
   1. Mitruka K,
   2. Thornton K,
   3. Cusick S,
   4. et al

   . Expanding Primary Care Capacity to Treat Hepatitis C Virus Infection Through an Evidence-Based Care Model—Arizona and Utah, 2012–2014. MMWR Morb Mortal Wkly Rep 2014;63:393–8.

   OpenUrlPubMed
2. 2.↵
   1. Huffman MM,
   2. Mounsey AL

   . Hepatitis C for primary care physicians. J Am Board Fam Med 2014;27:284–91.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Kottilil S,
   2. Wright M,
   3. Polis MA,
   4. Masur H

   . Treatment of Hepatitis C virus infection: Is it time for the internist to take the reins? Ann Intern Med 2014;161:443–4.

   OpenUrl
4. 4.↵
   1. Arora S,
   2. Thornton K,
   3. Murata G,
   4. et al

   . Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011;364:2199–207.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Mainous AG 3rd.,
   2. Seehusen D,
   3. Shokar N

   . CAFM Educational Research Alliance (CERA) 2011 Residency Director Survey: background, methods, and respondent characteristics. Fam Med 2012;44:691–3.

   OpenUrlPubMed
6. 6.↵
   Labcorp. Hepatitis C virus. 2011. Available from: https://www.labcorp.com/wps/wcm/connect/aeceb80045217a569bd7bfc88514224c/LabCorp+Virology+Report+Hepatitis+C+Virus.pdf?MOD=AJPERES&CACHEID=aeceb80045217a569bd7bfc88514224c. Accessed on May 28, 2015.
7. 7.↵
   1. Clark EC,
   2. Yawn BP,
   3. Galliher JM,
   4. Temte JL,
   5. Hickner J

   . Hepatitis C identification and management by family physicians. Fam Med 2005;37:644–9.

   OpenUrlPubMed
8. 8.↵
   1. Edlin BR

   . Sp473. Eradication of hepatitis C in persons with limited access to health care. Presented at Digestive Disease Week, Washington, DC, May 15–19, 2015.
9. 9.↵
   1. Barua S,
   2. Greenwald R,
   3. Grebely J,
   4. Dore GJ,
   5. Swan T,
   6. Taylor LE

   . Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Int M 2015;163:215–23.

   OpenUrl
10. 10.↵
    1. Losa Iglesias ME,
    2. Becerro de Bengoa Vallejo R,
    3. Salvadores Fuentes P

    . Moral distress related to ethical dilemmas among Spanish podiatrists. J Med Ethics 2010;36:310–4.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Thomas TA,
    2. McCullough LB

    . A philosophical taxonomy of ethically significant moral distress. J Med Philos 2015;40:102–20.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Jameton A

    . Dilemmas of moral distress: Moral responsibility and nursing practice. AWHONNS Clin Issues Perinat Womens Health Nurs 1992;4:542–51.

    OpenUrl
13. 13.↵
    1. Leggett JM,
    2. Wasson K,
    3. Sinacore JM,
    4. Gamelli RL

    . A pilot study examining moral distress in nurses working in one United States burn center. J Burn Care Res 2013;34:521–8.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Camminati CW,
    2. Simha A,
    3. Kolb NR,
    4. Prasad R

    . Intent to Build Hepatitis C Treatment Capacity Within Family Medicine Residencies: A Nationwide Survey of Program Directors: A CERA Study. Fam Med 2016;48:631–4.

    OpenUrl
15. 15.↵
    American Association for the Study of Liver Diseases, Infectious Diseases Society of America. Recommendations for testing, managing and treating hepatitis C. October 28, 2016. Available from: http://www.hcvguidelines.org/.
16. 16.↵
    1. Darlington RB,
    2. Hayes AF

    . Regression analysis and linear models: Concepts, applications, and implementation. New York, NY: Guilford Publications; Aug 22, 2016.
17. 17.↵
    1. Linas BP,
    2. Barter DM,
    3. Morgan JR,
    4. et al

    . The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med 2015;162:619–29.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Grebely J,
    2. Matthews GV,
    3. Hellard M,
    4. et al

    . Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. J Hepatol 2011;55:76–85.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Elpern EH,
    2. Covert B,
    3. Kleinpell R

    . Moral distress of staff nurses in a medical intensive care unit. Am J Crit Care 2005;14:523–30.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Charles C.,
    2. Gafni A.,
    3. Whelan T

    . Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci & Med 1997;44:681–692.

    OpenUrlCrossRefPubMedWeb of Science